These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26728318)

  • 1. Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.
    Maekawa T; Briones RA; Resuello RR; Tuplano JV; Hajishengallis E; Kajikawa T; Koutsogiannaki S; Garcia CA; Ricklin D; Lambris JD; Hajishengallis G
    J Clin Periodontol; 2016 Mar; 43(3):238-49. PubMed ID: 26728318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.
    Bostanci N; Bao K; Li X; Maekawa T; Grossmann J; Panse C; Briones RA; Resuello RRG; Tuplano JV; Garcia CAG; Reis ES; Lambris JD; Hajishengallis G
    J Proteome Res; 2018 Sep; 17(9):3153-3175. PubMed ID: 30111112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.
    Maekawa T; Abe T; Hajishengallis E; Hosur KB; DeAngelis RA; Ricklin D; Lambris JD; Hajishengallis G
    J Immunol; 2014 Jun; 192(12):6020-7. PubMed ID: 24808362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
    Gürkan A; Cinarcik S; Hüseyinov A
    J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
    Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
    J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammation.
    Hasturk H; Hajishengallis G; ; Lambris JD; Mastellos DC; Yancopoulou D
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-Dependent Mechanisms and Interventions in Periodontal Disease.
    Hajishengallis G; Kajikawa T; Hajishengallis E; Maekawa T; Reis ES; Mastellos DC; Yancopoulou D; Hasturk H; Lambris JD
    Front Immunol; 2019; 10():406. PubMed ID: 30915073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates.
    Kajikawa T; Briones RA; Resuello RRG; Tuplano JV; Reis ES; Hajishengallis E; Garcia CAG; Yancopoulou D; Lambris JD; Hajishengallis G
    Mol Ther Methods Clin Dev; 2017 Sep; 6():207-215. PubMed ID: 28879212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of locally delivered minocycline microspheres on markers of bone resorption.
    Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV
    J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.
    Hajishengallis G; Hajishengallis E; Kajikawa T; Wang B; Yancopoulou D; Ricklin D; Lambris JD
    Semin Immunol; 2016 Jun; 28(3):285-91. PubMed ID: 27021500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
    Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
    J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
    Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H
    J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy.
    Kurgan Ş; Önder C; Balcı N; Fentoğlu Ö; Eser F; Balseven M; Serdar MA; Tatakis DN; Günhan M
    J Periodontal Res; 2017 Jun; 52(3):574-581. PubMed ID: 27781272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
    Konopka L; Pietrzak A; Brzezińska-Błaszczyk E
    J Periodontal Res; 2012 Dec; 47(6):681-8. PubMed ID: 22510045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milk fat globule epidermal growth factor 8 inhibits periodontitis in non-human primates and its gingival crevicular fluid levels can differentiate periodontal health from disease in humans.
    Kajikawa T; Meshikhes F; Maekawa T; Hajishengallis E; Hosur KB; Abe T; Moss K; Chavakis T; Hajishengallis G
    J Clin Periodontol; 2017 May; 44(5):472-483. PubMed ID: 28207941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adjunctive use of green tea dentifrice in periodontitis patients - A Randomized Controlled Pilot Study.
    Hrishi TS; Kundapur PP; Naha A; Thomas BS; Kamath S; Bhat GS
    Int J Dent Hyg; 2016 Aug; 14(3):178-83. PubMed ID: 25690541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydrosoluble chlorine-mediated antimicrobial photodynamic therapy on clinical parameters and cytokine profile in ligature-induced periodontitis in dogs.
    Sorkhdini P; Moslemi N; Jamshidi S; Jamali R; Amirzargar AA; Fekrazad R
    J Periodontol; 2013 Jun; 84(6):793-800. PubMed ID: 22813345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gingival crevicular fluid levels of protease-activated receptors type 1 and type 2 in diabetic patients with periodontitis.
    Abreu IS; Euzebio Alves VT; Benedete AP; Bueno da Silva HA; França BN; Saraiva L; Lima LA; Carvalho MH; Holzhausen M
    J Periodontal Res; 2016 Oct; 51(5):577-85. PubMed ID: 26564991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory effect of locally delivered nano-doxycycline gel in therapy of chronic periodontitis.
    Madi M; Pavlic V; Samy W; Alagl A
    Acta Odontol Scand; 2018 Jan; 76(1):71-76. PubMed ID: 28959907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.